Scott Chasalow
About Scott Chasalow
Scott Chasalow is the Director and Head of Translational Bioinformatics Methodology at Bristol-Myers Squibb in New Jersey, United States. He has extensive experience in bioinformatics and statistics, having held various roles at Bristol-Myers Squibb, Monsanto Company, Cereon Genomics, Wageningen Agricultural University, Biomathematics & Statistics Scotland, and Cornell University.
Title
Scott Chasalow is the Director, Head Of Translational Bioinformatics Methodology at Bristol-Myers Squibb in New Jersey, United States.
Company
Scott Chasalow has been part of Bristol-Myers Squibb since 2003. He has held multiple roles including Principal Statistician, Associate Director, Senior Principal Scientist in Translational Bioinformatics, and currently, Director, Head Of Translational Bioinformatics Methodology.
Career at Bristol-Myers Squibb
Scott Chasalow began his tenure at Bristol-Myers Squibb in 2003 as a Principal Statistician. Over the years, he progressed to roles such as Associate Director, Senior Principal Scientist in Translational Bioinformatics, and has been leading the Translational Bioinformatics Methodology team since 2017.
Previous Industry Roles
Before joining Bristol-Myers Squibb, Scott Chasalow held various statistical roles in different organizations. He was a Senior Statistician at Monsanto Company and Cereon Genomics, a Research Statistician at Wageningen Agricultural University, and a Statistician at Biomathematics & Statistics Scotland.
Academic Background
Scott Chasalow holds a Ph.D. from the University of California, Berkeley, where he also completed his Master's degree in Biochemistry. He earned his Bachelor of Arts from Cornell University.